Back to search

Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines

Data up to Jan 2025

Published2008
Citations84
References25

Total Citations Per Year

Abstract

References (25)

Guide for the Care and Use of Laboratory Animals

2011 • 15,863 citations

Cancer Statistics, 2004

2004 • 4,026 citations

Epidermal growth factor-related peptides and their receptors in human malignancies

1995 • 2,689 citations

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

2005 • 1,081 citations

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

2005 • 948 citations

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

1995 • 791 citations

Efficient production of high specific activity 64Cu using a biomedical cyclotron

1997 • 514 citations

Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals

2006 • 281 citations

Epidermal growth factor receptor: a promising target in solid tumours

2003 • 250 citations

Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.

1999 • 245 citations

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

2007 • 239 citations

Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer

2005 • 237 citations

Molecular Determinants of Cetuximab Efficacy

2005 • 233 citations

An Assessment of the Effects of Shell Cross-Linked Nanoparticle Size, Core Composition, and Surface PEGylation on in Vivo Biodistribution

2005 • 223 citations

Receptor-Binding, Biodistribution, and Metabolism Studies of64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors

2008 • 114 citations

Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix

2004 • 108 citations

Expression of Epidermal Growth Factor Receptor in Carcinoma of the Cervix

1996 • 89 citations

Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64

2006 • 86 citations

Correlation between Expression of EGFR and the Prognosis of Patients with Cervical Carcinoma

2002 • 62 citations

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance

2005 • 49 citations

Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer

1998 • 48 citations

Conjugation of Monoclonal Antibodies with TETA Using Activated Esters: Biological Comparison of64Cu-TETA-1A3 with64Cu-BAT-2IT-1A3

2001 • 45 citations

A fluorescent orthotopic model of metastatic cervical carcinoma

2004 • 34 citations

HPV vaccination with Gardasil®: a breakthrough in women’s health

2006 • 26 citations

Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: Evidence for down-regulation in cervical cancer

1997 • 24 citations

Cited By (0)

Loading...
Correlating EGFR Expression with Receptor-Binding Properties and Internalization of… (2008) – Journal of Nuclear Medicine | Metascience Observatory Explorer